scorecardresearch
Thursday, March 28, 2024
TopicVaccine

Topic: Vaccine

If I had Covid-19 am I immune? This is what scientists know so far

Based on research so far, it’s reasonable to assume that most people who’ve had Covid-19 are less likely to be re-infected, and less likely to get a severe case if they do.

UK begins trial to see if Hydroxychloroquine prevents Covid-19

The trial will enroll 40,000 healthcare workers across the world and they will be given either hydroxychloroquine or a placebo for three months.

US raises ante in race for coronavirus vaccine with pledge of $1.2 billion to AstraZeneca

President Trump is pushing his way toward the front of the line to secure a shot to protect Americans from the outbreak and allow business to resume.

Drug trial of antiviral Avignan continues in Japan despite inconclusive interim result

China will invest an estimated $1.4 trillion over six years, calling on urban govts & pvt. tech giants to roll out everything from wireless networks to artificial intelligence.

Moderna shares fall from all-time high as euphoria around Covid vaccine data wears off

Moderna's shares, which nearly made an MIT professor a billionaire, began to slide after a report from the health publication Stat highlighted the early nature of the vaccine data.

Moderna’s clinical trial raises Covid vaccine hope, and a look at other potential vaccines

In episode 474 of #CutTheClutter, Shekhar Gupta looks at the potential Covid-19 vaccines being developed across the world.

MIT professor’s stake in biotech firm Moderna Inc on brink of topping $1 billion

Bob Langer’s 3.2% holding rose to $934.3 million Monday after the firm reported encouraging early trial results for an experimental Covid-19 vaccine.

Vaccine developers like Moderna need to take their time

Moderna announced the first reported data from human trials. That’s good news, but the project ahead will be harder to accomplish with speed.

Speed, reach, efficacy: How 3 challenges to creating a corona vaccine are being overcome

The coronavirus vaccine needs to be available in all parts of the world to ensure that a reservoir of the virus does not remain. Work is going on in record time to achieve that.

Eradicating Covid-19 might justify risky vaccine trials

The idea of infecting healthy subjects with Covid-19 might strike as repellent, yet many scientists and policy makers say it’s worth thinking about.

On Camera

Social media has made news more graphic. Torture by Russian military is latest example

Before social media, depiction of violence on news was the exception—graphic visuals were either not shown on TV or in newspapers or the images were blurred. This is no longer the case.

Profit margins in lottery industry are tiny. Here’s how Future Gaming paid for its electoral bonds

Neither state govts nor companies earn large profits from lotteries. However, a look at the system shows there’s ample evidence of murky dealings and financial irregularities. 

BRO connects new axis to Ladakh, to be shortest route

The all-weather Nimmu-Padam-Darcha Road will connect Manali to Leh through Darcha and Nimmu on Kargil-Leh Highway.

For BJP, Kejriwal is an idea whose time has come to be destroyed

The ‘idea’ Kejriwal's politics grew around was a no-holds-barred fight against corruption. That is the reason Modi govt has now tarred him and his entire party with the same paint.